SNDX
Syndax Pharmaceuticals Inc
18.20$
+1.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Syndax Pharmaceuticals Inc (SNDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -30 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -45 | -41 | -84 | -72 | -62 | -57 | -95 | -88 | -71 | -69 | -50 | -30 | -221 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | -0.2 | 0.0 | 0.0 | 0.0 | -0.2 | |
| 8.3 | 8.3 | 8.9 | 9.9 | 12 | 12 | 10 | 14 | 12 | 11 | 12 | 14 | 49 | |
| 1.6 | 26 | -16 | -10 | 13 | 27 | -17 | -27 | -23 | -12 | -19 | 24 | -30 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.2 | |
| 40 | -16 | -99 | 62 | 87 | -269 | 94 | 42 | 72 | 82 | 38 | -17 | 175 | |
| 1.9 | 258 | 2.2 | 0.7 | 3.1 | 347 | 0.9 | 0.6 | 6.3 | 5.9 | 7.9 | 253 | 273 | |
| -2.7 | 201 | -181 | -9.2 | 28 | 21 | -0.1 | -45 | 8.2 | 18 | -4.0 | 206 | 228 | |
| -45 | -41 | -84 | -72 | -62 | -57 | -95 | -88 | -71 | -70 | -50 | -30 | -221 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.